Literature DB >> 28986095

Modulation of mitochondrial dynamics by treadmill training to improve gait and mitochondrial deficiency in a rat model of Parkinson's disease.

Chieh-Sen Chuang1, Jui-Chih Chang2, Fu-Chou Cheng3, Ko-Hung Liu2, Hong-Lin Su4, Chin-San Liu5.   

Abstract

PURPOSE: Parkinson's disease (PD) is a progressive degenerative central nervous system disorder that particularly impairs motor function. As PD advances, gait disorders become more pronounced and are often difficult to treat with current pharmacological therapies. Physical activity improves both mobility in and the daily living activities of patients with PD. Mitochondrial alterations and oxidative stress contribute to PD progression. Therefore, the association between mitochondria and exercise in PD and the implicated regulation of mitochondrial proteins was explored in this study.
METHODS: In this study, we developed a unilateral 6-hydroxydopamine rat model of PD and executed 4weeks of treadmill training. Motor behavior was evaluated through gait change analysis (the CatWalk method) and rotational testing. The viability of dopaminergic neurons, mitochondrial function, and oxidative stress in the substantia nigra and striatum were investigated through Western blot and immunohistochemical staining. KEY
FINDINGS: Treadmill training improved the performance of gait parameters in terms of maximal area, swing speed, stride length, and stance phase; treadmill training also reduced methamphetamine-induced rotation. This training not only improved dopaminergic neuron viability but also recovered mitochondrial function and attenuated oxidative stress in PD rats. The mechanism may be associated with the facilitation of mitochondrial turnover, including facilitation of mitochondrial fusion, fission, and clearance accompanying increased quantities of mitochondria. SIGNIFICANCE: Treadmill exercise improved gait speed and balance, reduced oxidative stress, improved mitochondrial fusion and fission, increased mitochondrial amounts, and potentially attenuated dopaminergic neuron degeneration. Consequently, mitochondrial quality was improved in PD rats.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal behavior; Mitochondria; Oxidative stress; Parkinson's disease; Treadmill

Mesh:

Year:  2017        PMID: 28986095     DOI: 10.1016/j.lfs.2017.10.003

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Dietary management and physical exercise can improve climbing defects and mitochondrial activity in Drosophila melanogaster parkin null mutants.

Authors:  Rijan Bajracharya; J William O Ballard
Journal:  Fly (Austin)       Date:  2018-08-01       Impact factor: 2.160

Review 2.  Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.

Authors:  Maryam Abrishamdar; Maryam Sadat Jalali; Yaghoob Farbood
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

3.  Neuroprotective Effect of Dioscin against Parkinson's Disease via Adjusting Dual-Specificity Phosphatase 6 (DUSP6)-Mediated Oxidative Stress.

Authors:  Zhang Mao; Meng Gao; Xuerong Zhao; Lili Li; Jinyong Peng
Journal:  Molecules       Date:  2022-05-14       Impact factor: 4.927

4.  Study on Effect of Striatal mGluR2/3 in Alleviating Motor Dysfunction in Rat PD Model Treated by Exercise Therapy.

Authors:  Ping Chen; Xiaodong Li
Journal:  Front Aging Neurosci       Date:  2019-10-02       Impact factor: 5.750

Review 5.  Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.

Authors:  Ewelina Palasz; Wiktor Niewiadomski; Anna Gasiorowska; Adrianna Wysocka; Anna Stepniewska; Grazyna Niewiadomska
Journal:  Front Neurol       Date:  2019-11-01       Impact factor: 4.003

Review 6.  Therapeutic non-invasive brain treatments in Alzheimer's disease: recent advances and challenges.

Authors:  Chongyun Wu; Luoman Yang; Shu Feng; Ling Zhu; Luodan Yang; Timon Cheng-Yi Liu; Rui Duan
Journal:  Inflamm Regen       Date:  2022-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.